High blood pressure trials in Mexico
10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Chihuahua City, Cuauhtémoc, D.F, Durango, Guadalajara, Mazatlán, Mérida, San Luis Potosí City, Veracruz, Zapopan
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - No phaseEnrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Veracruz
- Age
- 0 Minutes to 2 weeks
- People
- 8,000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Mérida, México, Mexico City, Monterrey, Torreón, Veracruz
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Aguascalientes, Apizaco, Chihuahua City, Durango, Guadalajara, Mexico City
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Guadalajara, Mexico City, Monterrey
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Iztapalapa, León, México, Mexico City
- Age
- 18 years and over
- People
- 35,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - No phaseTaking peopleVagal Stimulation Therapy and Preeclampsia
- Where
- Guadalajara, Tlajomulco de Zúñiga
- Age
- 18 years and over
- People
- 210
- Run by
- Fundación Internacional René Mey
See details and how to joinNCT06953115 - No phaseNot yet taking people in MexicoCohort Study of Metabolic Disease and Hypertension
- Where
- Mexico City
- Age
- 18 years to 65 years
- People
- 2,500
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT07577063 - No phaseTaking peopleClinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.
- Where
- Mexico City
- Age
- 18 years and over
- People
- 1,000
- Run by
- Instituto de Oftalmología Fundación Conde de Valenciana
See details and how to joinNCT07178600 - No phaseTaking peoplesFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
- Where
- Mexico City
- Age
- 18 years and over
- People
- 9,132 worldwide
- Run by
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT04766866